Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

23,607 total articles

KBR and Trinzic to Host Separate Investor Days in New York City

KBR and Trinzic to Host Separate Investor Days in New York City

KBR announced separate Investor Day events in New York City for itself and its planned spin-off Trinzic, enabling investors to hear from leadership teams about strategic visions and financial outlooks ahead of the planned January 2027 separation. Post-spin-off, KBR will focus on its core lifecycle solutions business, while Trinzic will operate inde…

FTAI Acquires 27 Boeing 737-700 Aircraft from WestJet

FTAI Acquires 27 Boeing 737-700 Aircraft from WestJet

FTAI Aviation Ltd. announced the acquisition of 27 Boeing 737-700 aircraft from WestJet, including a sale-leaseback of 17 aircraft and purchase of 10 off-lease aircraft. This transaction expands FTAI's Strategic Capital portfolio and enhances its Aerospace Products business by increasing its supply of CFM56-7B engines and modules. The deal exemplif…

Hudbay Enhances Gold Production Profile at Snow Lake, Extends Reserve Mine Life to 18 Years and Identifies Further Growth Potential from Resource Conversion and the Britannia Gold Project

Hudbay Enhances Gold Production Profile at Snow Lake, Extends Reserve Mine Life to 18 Years and Identifies Further Growth Potential from Resource Conversion and the Britannia Gold Project

Hudbay Minerals updates Snow Lake mine plan, extending proven and probable reserve mine life by 2 years to 2043 and increasing total life-of-mine gold production by 60% to 2.8 million ounces. The plan includes higher mill throughput, improved gold recoveries, and strong capital discipline, supporting annual gold production averaging 185,000 ounces …

National Healthcare Properties Announces Definitive Agreement to Sell 40 Additional Outpatient Medical Facilities for $531 Million, Signs LOI for Remaining Four OMFs and Provides SHOP Acquisition Pipeline Update

National Healthcare Properties Announces Definitive Agreement to Sell 40 Additional Outpatient Medical Facilities for $531 Million, Signs LOI for Remaining Four OMFs and Provides SHOP Acquisition Pipeline Update

National Healthcare Properties announced the sale of 40 outpatient medical facilities for approximately $531 million and signed a letter of intent for the sale of its remaining four OMFs, effectively completing its exit from the outpatient medical facilities segment. The proceeds will be used to repay revolving credit facility debt, fund senior hou…

OMS Energy Technologies (NASDAQ: OMSE) Secures US$9.4 Million in New Orders, Including US$7.1 Million Competitive Tender Win from Saudi Aramco

OMS Energy Technologies (NASDAQ: OMSE) Secures US$9.4 Million in New Orders, Including US$7.1 Million Competitive Tender Win from Saudi Aramco

OMS Energy Technologies, a manufacturer of surface wellhead systems and OCTG for the oil and gas industry, announced new orders totaling $9.4 million. This includes a $7.1 million competitive tender win from Saudi Aramco, in addition to ongoing contracts, and a $2.3 million order from Pertamina Hulu Rokan. These orders reflect the company's strong …

Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis Manufacturing Platform to Create Stereo-defined siRNA

Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis Manufacturing Platform to Create Stereo-defined siRNA

Codexis, Inc. announced a collaboration with a pioneering siRNA drug developer to utilize its ECO Synthesis Manufacturing Platform for producing stereo-defined oligonucleotide fragments. This enzymatic approach may enhance scalability, efficiency, product purity, and stereochemical control compared to traditional synthesis methods, potentially bene…

Zymeworks Announces Updated 2026 Financial Guidance and Final Transaction Details Following Theravance Biopharma Acquisition

Zymeworks Announces Updated 2026 Financial Guidance and Final Transaction Details Following Theravance Biopharma Acquisition

Zymeworks Inc. has completed its acquisition of Theravance Biopharma, adding the marketed drug YUPELRI to its portfolio, expected to provide immediate accretive revenue and cash flow. The company has updated its 2026 financial guidance with projected total revenue between $278 million and $292 million and Adjusted EBITDA of $114 million to $128 mil…

WEBUY GLOBAL LTD. Nearly Doubles First-Half 2026 Revenue to US$14.3 Million as Gross Profit Increases 132%

WEBUY GLOBAL LTD. Nearly Doubles First-Half 2026 Revenue to US$14.3 Million as Gross Profit Increases 132%

WEBUY GLOBAL LTD. reported a 94.4% year-over-year increase in revenue from continuing operations to $14.31 million and a 131.7% increase in gross profit to $1.83 million for the first half of 2026. Following the exit from grocery operations, the company’s packaged tours business drove growth, particularly in Singapore and Indonesia. The net loss na…

VSMC Celebrates the Grand Opening of Its First 300mm Fab in Singapore

VSMC Celebrates the Grand Opening of Its First 300mm Fab in Singapore

VisionPower Semiconductor Manufacturing Company (VSMC), a joint venture between Vanguard International Semiconductor and NXP Semiconductors, inaugurated its first 12-inch wafer fab in Singapore. The fab has commenced risk production and is on track for volume production in early 2027, supporting technologies from 130nm to 40nm for various applicati…

HUTCHMED Initiates Global Trial of KRAS-EGFR-Antibody Conjugate Therapy HMPL-A830 in Patients with Solid Tumors

HUTCHMED Initiates Global Trial of KRAS-EGFR-Antibody Conjugate Therapy HMPL-A830 in Patients with Solid Tumors

HUTCHMED announced the initiation of the Phase Ia global clinical trial of HMPL-A830, a first-in-class antibody-targeted therapy conjugate designed to treat unresectable, advanced, or metastatic solid tumors with KRAS mutations. The trial aims to establish safety, tolerability, and preliminary efficacy, with GSK holding rights to commercialize the …

NIO Announces Definitive Agreements for Strategic Transaction with Geely Holding Group in Battery Swapping and Charging Businesses

NIO Announces Definitive Agreements for Strategic Transaction with Geely Holding Group in Battery Swapping and Charging Businesses

NIO Inc. announced agreements with subsidiaries of Zhejiang Geely Holding Group for a strategic partnership involving battery swapping and charging businesses. Geely will acquire a significant equity stake in NIO Power, NIO's subsidiary managing these businesses, with options for further investment. Concurrently, NIO will invest in Geely's battery …

MISSION SUCCESS: Rocket Lab Launches 97th Electron Mission

MISSION SUCCESS: Rocket Lab Launches 97th Electron Mission

Rocket Lab Corporation completed its 97th Electron rocket launch, deploying the 13th StriX satellite for Synspective's synthetic aperture radar constellation. The launch continues Rocket Lab's proven track record of reliable small satellite deployment and supports ongoing expansion plans through 14 more scheduled launches by decade-end.

Microbot Medical® Highlights Growth Strategy

Microbot Medical® Highlights Growth Strategy

Microbot Medical Inc. announced progress in its commercial growth strategy, including expansion to 12 U.S. sales territories with new hires and the addition of its first California customer. The company is optimizing its sales approach by engaging hospital Value Analysis Committees earlier to facilitate broader adoption of its LIBERTY robotic endov…

Calidi Biotherapeutics Received NYSE American Notification Letter Regarding Stockholders’ Equity Deficiency

Calidi Biotherapeutics Received NYSE American Notification Letter Regarding Stockholders’ Equity Deficiency

Calidi Biotherapeutics announced it received a notification from NYSE American that it does not meet the minimum stockholders' equity requirement of $4 million due to recent losses. The company must submit a plan by October 21, 2026, to regain compliance by March 21, 2028, or face potential delisting. Trading will continue with a '.BC' designation …